Director's Dealing • Nov 24, 2023
Director's Dealing
Open in ViewerOpens in native device viewer
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Hilja Ibert | |||
| 2 | Reason for the notification | ||||
| c) | Position/status | CEO | |||
| d) | Initial notification/ | Initial notification | |||
| Amendment | |||||
| 3 | Details of the issuer | ||||
| c) | Name | Gentian Diagnostics ASA | |||
| d) | LEI | 5967007LIEEXZXHNM861 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
| a) | Description of the financial instrument, type of instrument |
The exercise price for the options granted is NOK 40,71 being the being the average volume-weighted share price on the Oslo Stock Exchange for the past 10 trading days prior to 24 November 2023. |
|||
| Identification code | N/A | ||||
| b) | Nature of the transaction | Allocation of options | |||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| 0 | 139,962 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume |
139,962 | ||||
| - Price |
0 | ||||
| e) | Date of the transaction | 2023-11-23, 16:00 CET | |||
| f) | Place of the transaction | XOFF - Outside of trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated |
||||
|---|---|---|---|---|---|
| a) | Name | Torsten Knüttel | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Vice President R&D | |||
| b) | Initial notification/ | Initial notification | |||
| Amendment | |||||
| 3 | Details of the issuer | ||||
| a) | Name | Gentian Diagnostics ASA | |||
| b) | LEI | 5967007LIEEXZXHNM861 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
| a) | Description of the financial instrument, type of instrument |
The exercise price for the options granted is NOK 40,71 being the being the average volume-weighted share price on the Oslo Stock Exchange for the past 10 trading days prior to 24 November 2023. |
|||
| Identification code | N/A | ||||
| b) | Nature of the transaction |
Allocation of options | |||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| 0 | 30,000 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume |
30,000 | ||||
| - Price |
0 | ||||
| e) | Date of the transaction | 2023-11-23, 16:00 CET | |||
| f) | Place of the transaction | XOFF - Outside of trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Aleksandra Havelka | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Chief Scientific Officer | |||
| b) | Initial notification/ | Initial notification | |||
| Amendment | |||||
| 3 | Details of the issuer | ||||
| a) | Name | Gentian Diagnostics ASA | |||
| b) | LEI | 5967007LIEEXZXHNM861 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
| a) | Description of the financial instrument, type of instrument Identification code |
The exercise price for the options granted is NOK 40,71 being the being the average volume-weighted share price on the Oslo Stock Exchange for the past 10 trading days prior to 24 November 2023. N/A |
|||
| b) | Nature of the transaction | Allocation of options | |||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| 0 | 30,000 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume |
30,000 | ||||
| - Price |
0 | ||||
| e) | Date of the transaction | 2023-11-23, 16:00 CET | |||
| f) | Place of the transaction | XOFF - Outside of trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
|---|---|---|---|---|---|---|
| a) | Name | Markus Jaquemar | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Vice President Sales and Marketing | ||||
| b) | Initial notification/ | Initial notification | ||||
| Amendment | ||||||
| 3 | Details of the issuer | |||||
| a) | Name | Gentian Diagnostics ASA | ||||
| b) | LEI | 5967007LIEEXZXHNM861 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
| a) | Description of the financial instrument, type of instrument Identification code |
The exercise price for the options granted is NOK 40,71 being the being the average volume-weighted share price on the Oslo Stock Exchange for the past 10 trading days prior to 24 November 2023. N/A |
||||
| b) | Nature of the transaction | Allocation of options | ||||
| c) | Price(s) and volume(s) | |||||
| Price(s) | Volume(s) | |||||
| 0 | 40,000 | |||||
| d) | Aggregated information | |||||
| - Aggregated volume |
40,000 | |||||
| - Price |
0 | |||||
| e) | Date of the transaction | 2023-11-23, 16:00 CET | ||||
| f) | Place of the transaction | XOFF - Outside of trading venue |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.